AFP and hepatocellular carcinoma: GPC3, an oncofetal protein that is expressed on the cell surface of CTCs, was significantly upregulated in the early stage of HCC compared to AFP expression, and 43 out of the 68 (63.2%) AFP-negative patients had elevated GPC3 levels [27].